EUVIMEDEUVIMED entdecken
Crossref

N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification

Yulin Deng, Zeheng Tan, Shanghua Cai, Yuanfa Feng, Zhenfeng Tang, Jinchuang Li, Huichan He, Zhenjie Wu, Ren Liu, Huiting Huang, Jianheng Ye, Zhaodong Han und 1 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yulin Deng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Urology, Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medic…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenosine, Biomarkers, Tumor, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: N1-methyladenosine (m1A) RNA methylation is an emerging epigenetic modification. Its potential role in lipid metabolism and prognosis of prostate cancer (PCa) remains unexplored. OBJECTIVES: This study investigated the impact of m1A on lipid metabolism and PCa prognosis. METHODS: In this work, the landscape of genetic and expression variations of 10 widely recognized m1A regulators in PCa was revealed. Combining machine-learning strategies, the m1A modification patterns and corresponding characteristics of lipid metabolism of PCa samples from the cancer genome atlas program (TCGA) dataset were comprehensively analyzed. In vitro assays were performed to identify the role of TRMT61A, the key m1A regulator, on PCa cells. RESULTS: Two distinct m1A modification patterns and corresponding lipid metabolism profiles were identified in PCa. The m1A modification subgroup with a high risk of biochemical recurrence (BCR) has stronger mitochondrial metabolism and FA oxidation activity. A consensus m1A modification-related lipid metabolism score (mMLMS) was constructed to predict the BCR prognosis of patients with PCa. The mMLMS was shown to accurately predict the BCR prognosis of PCa within six external cohorts. Finally, TRMT61A was identified as the key m1A regulator related to mMLMS, and it was found to promote the progression of PCa in vitro. TRMT61A potentially enhances mitochondrial function and FA beta oxidation in PCa cells via the PI3K/AKT pathway. CONCLUSION: m1A RNA methylation patterns are associated with characteristics of lipid metabolism in PCa, providing a novel treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAdenosineBiomarkers, TumorNeoplasm Recurrence, LocalLipid MetabolismHumansMaleCell Line, TumorPrognosisMethylationGene Expression Regulation, NeoplasticEpigenesis, GeneticMethyltransferasesRNARNA Methylation

Stichwörter der Autor:innen

Lipid metabolismMachine learningN1-methyladenosinePrognosisProstate cancer

Substanzen

AdenosineBiomarkers, Tumor1-methyladenosineMethyltransferasesRNA

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Urology, Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, 510120, Guangzhou, Guangdong, China; Guangzhou National…
  • Department of Urology, Zhujiang Hospital, Southern Medical University, 510260, Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Laboratory of Urology, Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, 510120, Guangzhou, Guangdong, China.
  • Guangzhou National Laboratory, No. 9 XingDaoHuanBei Road, Guangzhou International Bio Island, 510005, Guangzhou, Guangdong, China.
  • Department of Urology, Guangzhou First People's Hospital, South China University of Technology, 510180, Guangzhou, Guangdong, China.
  • Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, Guangdong, China.

Förderung

  • Guangzhou Municipal Science and Technology Project
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • Science and Technology Development Fund

Zitieren

APA

Deng, Y., Tan, Z., Cai, S., Feng, Y., Tang, Z., Li, J., He, H., Wu, Z., Liu, R., Huang, H., Ye, J., Han, Z., & Zhong, W. (2024). N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113404

Vancouver

Deng Y, Tan Z, Cai S, Feng Y, Tang Z, Li J, et al. N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113404

BibTeX
@article{Deng2024,
  author = {Deng, Yulin and Tan, Zeheng and Cai, Shanghua and Feng, Yuanfa and Tang, Zhenfeng and Li, Jinchuang and He, Huichan and Wu, Zhenjie and Liu, Ren and Huang, Huiting and Ye, Jianheng and Han, Zhaodong and Zhong, Weide},
  title = {N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113404}
}
Kostenlos starten →